It does not receive public funding
Editor in chief:
CLARA MOSCHINI

Facebook Twitter Youtube Instagram LinkedIn


Do you want to access to this and other private contents?
Log in if you are a subscriber or click here to request service

Pharmanutra, nine months of growth

Revenues up 13.3%, EBITDA up 2.5% for the Pisa-based nutraceutical company.

Pharmanutra shares, a company specializing in mineral-based nutritional supplements and medical devices for muscles and joints, enjoyed a sunny day today, rising more than 8% on the Milan Stock Exchange. This was due to a "strong increase in operating growth, including the initial contribution of revenues generated by new markets" recorded in the first nine months of 2025. The data, released by the...

fc - 55204

EFA News - European Food Agency
Similar